These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7576004

  • 1. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R, Parthasarathy R.
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [Abstract] [Full Text] [Related]

  • 2. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
    Parthasarathy LK, Seelan RS, Wilson MA, Vadnal RE, Parthasarathy RN.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726
    [Abstract] [Full Text] [Related]

  • 3. Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.
    Pachter JA.
    Mol Pharmacol; 1991 Jul; 40(1):107-11. PubMed ID: 1649963
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitors of inositol monophosphatase.
    Fauroux CM, Freeman S.
    J Enzyme Inhib; 1999 Jul; 14(2):97-108. PubMed ID: 10445037
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
    Faraci WS, Zorn SH, Bakker AV, Jackson E, Pratt K.
    Biochem J; 1993 Apr 15; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular characterization of coding and untranslated regions of rat cortex lithium-sensitive myo-inositol monophosphatase cDNA.
    Parthasarathy L, Parthasarathy R, Vadnal R.
    Gene; 1997 May 20; 191(1):81-7. PubMed ID: 9210592
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: molecular and behavioral aspects.
    Levi I, Eskira Y, Eisenstein M, Gilon C, Hoffman A, Tal-Gan Y, Fanous J, Bersudsky Y, Belmaker RH, Agam G, Almog O.
    Eur Neuropsychopharmacol; 2013 Dec 20; 23(12):1806-15. PubMed ID: 23619164
    [Abstract] [Full Text] [Related]

  • 13. Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1.
    Ohnishi T, Ohba H, Seo KC, Im J, Sato Y, Iwayama Y, Furuichi T, Chung SK, Yoshikawa T.
    J Biol Chem; 2007 Jan 05; 282(1):637-46. PubMed ID: 17068342
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Calbindin D28k and S100B have a similar interaction site with the lithium-inhibitable enzyme inositol monophosphatase-1: a new drug target site.
    Agam G, Almog O.
    J Med Chem; 2015 Feb 26; 58(4):2042-4. PubMed ID: 25665147
    [Abstract] [Full Text] [Related]

  • 17. The purification and properties of myo-inositol monophosphatase from bovine brain.
    Gee NS, Ragan CI, Watling KJ, Aspley S, Jackson RG, Reid GG, Gani D, Shute JK.
    Biochem J; 1988 Feb 01; 249(3):883-9. PubMed ID: 2833231
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.